Research Article

Wnt/β-Catenin, Carbohydrate Metabolism, and PI3K-Akt Signaling Pathway-Related Genes as Potential Cancer Predictors

Table 4

Performances of pathway-related genes and DEGs in test sets.

GenesTest set
COAD (%) (normal/tumor = 9/123)BRCA (%) (normal/tumor = 35/332)STAD (%) (normal/tumor = 11/112)PRAD (%) (normal/tumor = 16/149)
SVMRFDTKNNSVMRFDTKNNSVMRFDTKNNSVMRFDTKNN

Wnt100.0099.9094.0399.8699.9597.6488.79100.0099.2698.7079.1399.7595.7695.5576.6595.26
Ca-Me100.00100.0099.18100.0099.9699.5088.42100.0099.1097.8875.0497.4494.7596.9579.6795.11
PI3K100.00100.00100.0099.9599.9299.4398.4199.6699.3598.5384.5797.4496.5691.6186.0195.91
TLR100.0097.0188.48100.0099.8799.3590.1799.4498.6298.0186.3695.3793.2092.0578.5686.79
TH100.0099.7299.1899.8699.9398.8683.3899.5799.4398.4580.9297.9396.6089.5364.9191.42
RPSC100.0099.8694.0399.9599.9399.9394.1399.8499.2698.2583.6898.7494.6793.1279.8895.05
DEGs100.00100.00100.00100.00100.0099.9699.0399.2999.3599.1088.6796.0293.3792.7685.4891.23

Note. COAD, colorectal cancer; BRCA, breast cancer; STAD, gastric cancer; PRAD, prostate cancer; Wnt, Wnt signaling pathway; Ca-Me, carbohydrate metabolism signaling pathway; PI3K, PI3K-Akt signaling pathway; TLR, toll-like receptor signaling pathway; TH, thyroid hormone signaling pathway; RPSC, signaling pathways regulating pluripotency of stem cells.